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AbstrAct
Introduction The STrengthening the Reporting of 
OBservational studies in Epidemiology (STROBE) Statement 
was developed in response to inadequate reporting of 
observational studies. In recent years, several extensions 
to STROBE have been created to provide more nuanced 
field-specific guidance for authors. The content and the 
prevalence of extension endorsement have not yet been 
assessed. Accordingly, there are two aims: (1) to classify 
changes made in the extensions to identify strengths and 
weaknesses of the original STROBE checklist and (2) to 
determine the prevalence and typology of endorsement by 
journals in fields related to extensions.
Methods and analysis Two independent researchers 
will assess additions in each extension. Additions will 
be coded as ‘field specific’ (FS) or ‘not field specific’ 
(NFS). FS is defined as particularly relevant information 
for a single field and guidance provided generally 
cannot be extrapolated beyond that field. NFS is 
defined as information that reflects epidemiological or 
methodological tenets and can be generalised to most, if 
not all, types of observational research studies. Intraclass 
correlation will be calculated to measure reviewers’ 
concordance. On disagreement, consensus will be 
sought. Individual additions will be grouped by STROBE 
checklist items to identify the frequency and distribution 
of changes. Journals in fields related to extensions 
will be identified through National Library of Medicine 
PubMed Broad Subject Terms, screened for eligibility and 
further distilled via Ovid MEDLINE® search strategies for 
observational studies. Text describing endorsement will 
be extracted from each journal’s website. A classification 
scheme will be created for endorsement types and the 
prevalence of endorsement will be estimated. Analyses will 
use NVivo V.11 and SAS University Edition.
Ethics and dissemination This study does not require 
ethical approval as it does not involve human participants. 
This study has been preregistered on Open Science 
Framework.
IntroductIon
The STrengthening the Reporting of OBser-
vational studies in Epidemiology (STROBE) 
Statement was developed in 2007 in response 
to the pervasiveness of inadequate reporting 
of observational studies. STROBE provides 
a checklist of items that serve as a reference 
for how to report sufficient information for 
observational research involving cohort, 
case–control and cross-sectional studies.1 The 
guidelines have been endorsed by the Interna-
tional Committee of Medical Journal Editors 
(ICMJE) and the accompanying checklist is 
sometimes explicitly used as a requirement 
for manuscript submission.2 However, there is 
no standard method of endorsement by jour-
nals and little is known about the most effec-
tive ways to apply the guidelines in practice.3–5 
Regarding the reporting of clinical trials, 
requiring a completed Consolidated Stan-
dards of Reporting Trials (CONSORT) check-
list on submission of a manuscript has been 
shown to lead to improvements in reporting.6 
However, some journals do not want to take 
responsibility for guideline enforcement and 
many overlook non-adherence to guidelines; 
editors have expressed beliefs that their jour-
nal’s current policies are adequate or that 
they fear losing authors to other journals 
that have less strict requirements for publi-
cation.7–9 Editors may also be unaware of the 
existence of guidelines, as demonstrated by 
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Protocol
strengths and limitations of this study
 ► Our systematic approach to qualitatively assess the 
content of the additions made in the STrengthening 
the Reporting of OBservational studies in 
Epidemiology extensions provides a comprehensive 
overview of the types of changes made and can 
identify redundancies and problem areas.
 ► Our method involves standardised search strategies 
in Ovid Medline, designed to capture a representative 
sample and circumvent issues of subjectivity in the 
identification of eligible journals.
 ► This study will create an open source corpus 
of recent observational studies spanning seven 
fields which future researchers can use  to assess 
completeness of reporting or other topics of interest.
 ► The bibliometric aspect of this study only focuses 
on seven extensions and fields so results are not 
generalisable to other studies.
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low endorsement rates by journals in dentistry,10 veter-
inary medicine7 and urology.11 On the other hand, the 
evidence for the endorsement of STROBE is also mixed. 
Endorsement was not shown to be associated with better 
reporting for items related to confounding, regardless of 
strength.12
Several field-specific extensions to STROBE have 
been designed in recent years in an effort to promote 
complete reporting, provide more nuanced guidance 
for authors and perhaps address editor’s concerns 
that STROBE is not focused enough for their journal. 
Extensions for other reporting guidelines are common; 
however, the creation of extensions for STROBE seems 
to outpace those for other reporting guidelines such as 
the CONSORT.13 Since the publication of STROBE in 
2007, 13 extensions have been published and indexed 
by the Enhancing the QUAlity and Transparency Of 
health Research (EQUATOR) Network, an international 
collaboration that promotes transparent and accurate 
reporting and indexes reporting guidelines.14 In contrast, 
CONSORT was first published in 1996, updated in 2001 
and further revised in 2010, yet only 17 extensions have 
been published during that period.15 The reason behind 
the difference in the pacing of publications of extensions 
is unclear. Perhaps the concept of field-specific extensions 
to reporting guidelines was pioneered by CONSORT, 
thus making the idea more commonplace for subsequent 
reporting guidelines. Alternatively, the complexity of the 
types of observational research studies may require more 
guidance due to the wide variety of methods employed 
in observational studies. Regardless of the reasoning, it is 
evident that authors are still perceiving a need to provide 
more guidance on how to report information about their 
studies. However, until now, many of these initiatives have 
not been evaluated.
Extensions to STROBE offer a potential new avenue 
for promoting more complete reporting but their use 
has been largely unassessed and, similar to STROBE, 
they may face implementation and usage problems.3 7 
Being intended as general guidelines for observational 
studies, STROBE should include necessary information 
that is sufficient to most observational studies. For some 
fields, however, STROBE guidelines may not be sufficient 
due to specific requirements within the field. This gap 
is then covered by an extension for that field. However, 
when extensions include non-specific guidance that can 
be extrapolated to most observational studies (eg, details 
about participants, settings, confounders, follow-up, 
biases or any other general epidemiological constructs), 
it suggests potential deficiencies in STROBE checklist. If 
the content is already in STROBE, extension authors may 
have thought that it was not clearly communicated, or 
that it is necessary to include it in the checklist instead of 
being only in the explanation and elaboration document. 
While, if the content is not already in STROBE, extension 
authors may have identified a gap or insufficiency which 
should be considered as an addendum to STROBE. 
Therefore, by identifying non-specific or redundant 
guidance suggested in the STROBE extensions, we will 
be able to identify perceived gaps and deficiencies in the 
current STROBE checklist and potentially reduce future 
waste in the process of extension creation.
A perceived lack of confidence in reporting guide-
lines can impact journal editors’ willingness to endorse 
reporting guidelines. Currently, it is unclear if and how 
journals are encouraging or requiring authors to use 
STROBE extensions. As journals are key players influ-
encing the use and uptake of extensions, the prevalence 
and typology of extension endorsement is needed to 
understand the variety of methods employed to encourage 
transparent reporting. Data collected from this study can 
later be used as the groundwork for an evaluation of the 
impact of endorsement on the completeness of reporting.
Aims
The objectives of this study are twofold. First, to qualita-
tively assess and classify the changes made in the exten-
sions to help to identify the strengths and weaknesses of 
the original STROBE checklist; this will identify potential 
problem areas or deficiencies conveyed in extension addi-
tions. Second, we will estimate the prevalence of endorse-
ment in journals that publish observational studies from 
extension-related fields and create an endorsement 
typology to provide a finer detailed view of the promotion 
of the STROBE extensions.
MEthods And AnAlysIs
Qualitative assessment and analysis
The main focus of this phase will be on coding the addi-
tions that are made in each extension. Coded additions 
will help to identify the strengths, weaknesses and redun-
dancies conveyed in the STROBE extensions to provide 
guidance for modifications to the original STROBE 
checklist and to identify target areas for future educa-
tional interventions.
We will assess the content of 13 STROBE exten-
sions which were identified through the EQUATOR 
Network website as well as through a PubMed search 
for STROBE-related publications. Two independent 
reviewers (DH, MKS) will code the additions made in 
each STROBE extension; disagreement will be resolved 
by consensus. Each subitem on an extension that is 
attached to a STROBE checklist item will be coded 
individually by the relevant content area (eg, item five 
subitem additions a, b and c will be counted and coded 
as three separate items). Each subitem will also be coded 
as ‘field specific’ (FS) or ‘not field specific’ (NFS). FS is 
defined as information that is particularly relevant for a 
single field and guidance provided cannot be generalised 
beyond that particular extension’s field. Items which note 
phrases such as ‘including,’ ‘specifically,’ ‘for example’ 
and ‘eg,’ followed by a field-specific example, generally 
are considered to be field specific as these items are 
adding additional information specific to a certain topic 
area. NFS is defined as information that reflects general 
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Table 1 Extensions eligible for assessment
Abbreviation Title/description Publication date
STREGA4 STrengthening the REporting of Genetic Association Studies 3 February 2009
STROBE-EULAR28* A EULAR extension of STROBE guidelines 4 June 2010
STROBE-ME29 STrengthening the Reporting of OBservational studies in Epidemiology—Molecular 
Epidemiology
24 October 2011
STROME-ID30 Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases  13 March 2014
STROBE-RDS31 Strengthening the Reporting of Observational Studies in Epidemiology for 
Respondent-Driven Sampling studies
1 May 2015
RECORD
32
REporting of studies Conducted using Observational Routinely collected health 
Data Statement
6 October 2015
STROBE-AMS33 Strengthening the Reporting of Observational Studies in Epidemiology for 
AntiMicrobial Stewardship
19 February 2016
*This extension does not have an official acronym. For simplicity’s sake, this will be used.
RECORD, REporting of studies Conducted using Observational Routinely-collected health Data; STREGA, STrengthening the REporting of 
Genetic Association Studies; STROBE, Strengthening the Reporting of Observational Studies in Epidemiology; STROBE-AMS, STROBE-
AntiMicrobial Stewardship; STROBE-EULAR, STROBE-European League Against Rheumatism; STROBE-ID, Infectious Diseases; STROBE-
ME, STROBE-Molecular Epidemiology; STROBE-RDS, STROBE-Respondent-Driven Sampling studies.
Table 2 Extensions not eligible for assessment
Abbreviation Title/description Publication date
MARE-S34 Medical Abortion Reporting of Efficacy—STROBE 23 April 2016
STROBE-NUT35 Strengthening the Reporting of Observational Studies in Epidemiology-NUTritional 
epidemiology
7 June 2016
ROSES-I36 CONSISE statement on the REporting of SEroepidemiologic Studies for influenza 17 July 2016
STROBE-SBR37 Strengthening the Reporting of Observational Studies in Epidemiology for 
Simulation-Based Research
26 July 2016
STROBE-NI38 Strengthening the Reporting of Observational Studies in Epidemiology for Newborn 
Infection
13 September 2016
STROBE-Vet39 Strengthening the Reporting of Observational Studies in Epidemiology—Veterinary 1 November 2016
MARE-S, Medical abortion reporting of efficacy; STROBE-NI, Strengthening the Reporting of Observational Studies in Epidemiology for 
Newborn Infection; STROBE-NUT, STROBE-Nutritional Epidemiology; ROSES-I, CONSISE statement on the reporting of Seroepidemiologic 
Studies for influenza; STROBE-SBR, STROBE-Simulation-based research; STROBE-Vet, STROBE-Veterinary.
epidemiological or methodological tenets and can be 
extrapolated to most, if not all, types of observational 
research studies.
For the subjective assessments of the field-specific or not 
field-specific nature of the additions (rated as binary yes 
or no), intraclass correlation (ICC) will be used to assess 
the inter-rater reliability (IRR). The ICC for the two raters 
will be calculated for ratings across all 13 extensions that 
involve the subjective assessment of an item as FS or not. 
This method was chosen because ICC does not take an 
all-or-nothing approach to agreement but rather it ‘incor-
porates the magnitude of disagreement to compute IRR 
estimates’.16 Descriptive statistics such as counts, means 
and percentages will be given.
Endorsement survey
Eligibility criteria
Extensions to the STROBE guidelines were identified 
through the EQUATOR Network website as well as 
through a search on PubMed. Extensions are eligible 
for assessment if at least 1 year has passed since publica-
tion as this allows for some time for endorsement and 
implementation. In the case of multiple publications of 
an extension, the earliest publication/availability date 
will be used to determine eligibility. As of 1 March 2017, 
eligible extensions are detailed in table 1, while ineligible 
extensions are detailed in table 2.
Identification of journals
Journals in fields related to extensions will be identified 
using the National Library of Medicine (NLM) catalogue 
which contains, among other things, ‘biomedical and 
health-related life sciences journals’ indexed in Medline. 
As of March 2017, there are over 5600 journals indexed.17 
This database was chosen for two primary reasons: 
(1) broad subject terms are used which allows for easy 
identification and segmentation of research fields for 
journals and topic areas for articles and (2) the segmen-
tation of other search engines, namely Clarivate Analytics 
Web of Science Journal List,18 did not clearly align with 
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Table 3 Broad subject terms
STROBE Extension Broad subject term(s)
STREGA Genetics, genetics, medical
STROBE-EULAR Rheumatology
STROBE-ME Molecular biology
STROME-ID Molecular biology, anti-infective 
agents
STROBE-RDS Public health
RECORD Health services, health services 
research
STROBE-AMS Anti-infective agents, drug therapy
RECORD, REporting of studies Conducted using Observational 
Routinely-collected health Data; STREGA, STrengthening the 
REporting of Genetic Association Studies; STROBE, Strengthening 
the Reporting of Observational Studies in Epidemiology; STROBE-
AMS, STROBE-AntiMicrobial Stewardship; STROBE-EULAR, 
STROBE-European League Against Rheumatism; STROBE-
ID, Infectious Diseases; STROBE-ME, STROBE-Molecular 
Epidemiology; STROBE-RDS, STROBE-Respondent-Driven 
Sampling studies.
extension fields and would result in more overwhelming 
searches with less certainty that potentially eligible jour-
nals would be identified.
Journals will be identified using the following search 
string in the NLM catalogue: pubmed (‘Broad subject 
terms’). If an extension reports search terms in their 
publication, these will be considered as a starting point. 
All search strategies were developed in collaboration with 
a medical librarian. Further details listing the individual 
broad subject terms used for each extension are detailed 
in table 3.
Screening
Journals will be manually screened to confirm that they 
publish in English, are in a relevant format (eg, not a text-
book, magazine, etc) and are currently publishing. From 
the remaining list of journals that are indexed in Medline, 
search strategies will be used to identify observational 
studies in the relevant topic areas (see online supple-
mentary file 1). The filter for observational studies is a 
combination of a study design search filter for cohort and 
case–control studies by BMJ Evidence Centre information 
specialists, Fraser et al’s work on identifying observational 
studies in surgical interventions and consultations with a 
medical librarian.19 20
From the remaining list of journals that publish 
observational studies, FS search strategies (detailed 
in online supplementary file 1) will be used. Exten-
sions were used as a starting point and extant systematic 
reviews provided additional guidance, particularly for 
RECORD and STROBE—AntiMicrobial Stewardship 
(STROBE-AMS).21 22 In the case of European League 
Against Rheumatism, a combination approach will not be 
used as this is the only extension where the broad subject 
term is the exact focus of the extension; the search 
strategy for observational studies will still be used.
The results of the Ovid Medline FS and observational 
search strategies will be compared with the list of jour-
nals that the search was run on to determine inclusion 
and exclusion. This combination approach will be used 
for several reasons. First, journal information from 
NLM is given in more structured manner and allows 
for easy matching between sets with overlapping Broad 
Subject Terms. For example, both STROBE-AMS and 
Strengthening the Reporting of Molecular Epidemi-
ology for Infectious Diseases (STROME-ID) use the term 
‘anti-infective agents’ while both STROBE-ME and 
STROME-ID use ‘molecular biology.’ This approach is 
also less resource intensive and allows us to more easily 
identify how many journals in each field publish obser-
vational studies, thus establishing the extent and impor-
tance of the issue.
Data extraction
Eligible journals and their websites will be searched 
exhaustively for any mention of STROBE extensions in 
their instructions for authors, guidelines for reviewers, 
other guidance documents or ethical policies. Data will be 
extracted by the first author (MKS). To inspect reliability, 
another researcher (DH) will extract data from 10% of 
the sample and agreement will be calculated. Primary 
data sources (ie, website pages) will be downloaded in pdf 
format and relevant text describing guideline endorse-
ment will be extracted and coded into a standard data 
extraction sheet in Excel. Although STROBE and its exten-
sions are the main focus of this investigation, we will also 
collect information about endorsement of other common 
guidelines such as CONSORT, Preferred Reporting Items 
for Systematic Reviews and Meta-Analyses (PRISMA), 
ICMJE’s Recommendations for the Conduct, Reporting, 
Editing and Publication of Scholarly work in Medical 
Journals and mentions of organisations like EQUATOR 
and Committee on Publication Ethics.13 15 23–25 This infor-
mation will be gathered to see if journals that endorse 
other reporting guidelines or ethical reporting guidance 
are more likely to endorse STROBE or an extension.
Altman and Hopewell’s classification schema will be 
used as a starting point for the development of a typology 
of endorsement for STROBE and extensions.6 26 27 The 
initial approach will be to codify endorsements into 
several categories of ranging from active, passive and 
not endorsing. Some examples include a requirement of 
a completed checklist with manuscript submission (eg, 
active), a suggestion that authors ‘should’ reference or 
follow a specific guideline (eg, passive strong), a vague 
suggestion that author should adhere to reporting guide-
lines (eg, passive moderate), a vague suggestion that 
authors should adhere to certain standards which include 
reference to reporting guidelines (eg, passive weak) or no 
explicit mention at all (eg, not endorsing).
In addition to information regarding support for 
STROBE and its extensions, general information about 
the journal such as impact factor, publisher and contact 
information for the editorial offices will be collected. For 
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the purposes of future analyses focused on completeness 
of reporting, it will also be noted if journals have recently 
launched and have not been publishing for at least 2 years 
prior to the publication of its related extension; this 
will ensure the ability to establish baseline data on the 
completeness of reporting. For example, STREGA was 
published in 2009, therefore journals must have begun 
publishing by 2007 to be included in latter assessments.
As publishers often provide additional resources for 
authors, we will collect information from the websites of 
publishers about their methods of endorsement. Endorse-
ment from publishers will be considered to be indirect 
methods of support as they require significant effort on 
the part of the user seeking the information. Information 
communicated directly through the journal’s website will 
be considered to be direct if it is supplied in immediately 
available resources to authors.
Statistical analyses
Endorsement, types of endorsement and journal charac-
teristics (eg, Impact factor, publisher) will be expressed 
using descriptive statistics such as counts, means/medians 
and percentages. For analyses comparing two binary vari-
ables (ie, endorsement of extensions and endorsement 
of other reporting guidelines), unadjusted ORs and 
their associated 95% CIs will be conducted. Differences 
in impact factors between endorsing and non-endorsing 
journals will be assessed with the Wilcoxon test of ranks, 
equivalent to the c-stat, c-index or area under the receiver 
operating characteristic curve. All CIs will be provided at 
the two-sided 95% level.
dIscussIon
An evaluation of the extensions provides a deeper under-
standing of content areas that are adequately detailed or 
in need of elaboration. By identifying the content areas 
that authors have difficulties with, the groundwork will be 
laid for an assessment into how authors currently use and 
understand STROBE and what difficulties they encounter 
with its implementation. This study will provide us with 
potential hypotheses for future survey for authors, focused 
both on the perceived sufficiency of STROBE and the 
extensions as this could be a barrier to use. For example, 
if we find non-specific additions in parts of STROBE, we 
may focus on those parts when inquiring authors’ opin-
ions about adequacy of STROBE. The qualitative assess-
ment will also allow us to identify key areas (eg, particular 
sections of the methods, results, conclusion) that may be 
commonly misunderstood to specifically probe authors 
about these points.
Results from this study will also provide estimates of the 
frequency and typology of endorsement. This dataset will 
allow journals to be targeted to promote guideline usage 
and will establish a groundwork for follow-up studies on 
attitudes related to endorsement of STROBE and its exten-
sions. Perhaps most importantly, this study will provide 
the foundation for assessing the impact that endorsement 
has on the completeness of reporting. The data collected 
through this study will generate important insights for the 
design of future studies such as feasibility or pilot studies 
to estimate the effects of endorsement. Perceived lack 
of tangible benefit due to a weak evidence base can be 
a major barrier to guideline use. Testing a relationship 
between endorsement and an increase in completeness of 
reporting can provide the much-needed data to address 
sceptic’s concerns about the tangible value of supporting 
STROBE and its extensions.
This study will solidify the scope of the problem of 
insufficient support and use of STROBE extensions, 
detail variability in endorsement typology and establish 
data for future studies focused on the effects of endorse-
ment on completeness of reporting and attitudes towards 
STROBE and its extensions.
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